• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南威尔士感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2,即新冠病毒)的住院患者肝脏血液检查异常的发生率、模式及严重程度

Incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with SARS-COV2 (COVID-19) in South Wales.

作者信息

Yeoman Andrew, Maggs Daniel Raun, Gardezi Syed A A, Haboubi Hasan Nadim, Yahya Muhammad Imran, Yousuf Fidan, Czajkowski Marek Alexander

机构信息

Gwent Liver Unit, Aneurin Bevan University Health Board, Newport, UK.

出版信息

Frontline Gastroenterol. 2020 Aug 21;12(2):89-94. doi: 10.1136/flgastro-2020-101532. eCollection 2021.

DOI:10.1136/flgastro-2020-101532
PMID:33617606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7873537/
Abstract

INTRODUCTION

SARS-CoV-2 (COVID-19) is a novel coronavirus that emerged in Wuhan, China in late 2019 and since become a global pandemic. As such, its clinical behaviour is a subject of much interest. Initial reports suggested a significant proportion of patients have abnormal liver blood tests. Gwent has experienced one of the highest incidences of COVID-19 infection in the UK, which itself has among the highest COVID-19 impacts worldwide.

METHOD

We set out to report the incidence, clinical pattern and severity of liver blood test abnormalities in hospitalised patients with confirmed COVID-19 in our institution over a 3-week period. Data on clinical outcomes such as admission to intensive therapy unit (ITU), hospital discharge and mortality were recorded.

RESULTS

318 hospitalised COVID-19 positive had liver blood tests available for analysis. Ninety-seven patients (31%) had one or more abnormal liver blood tests and were abnormal admission in 64%. Liver tests were predominantly cholestatic (72%) in contrast to other studies to date. Male gender and abnormal liver blood tests were associated with ITU admission.

CONCLUSIONS

Almost one-third of admissions with COVID-19 have abnormal LBTs which are typically mild and are associated with male gender. Importantly, we have identified that cholestatic patterns dominate but were not clearly associated with ITU admission or death.

摘要

引言

严重急性呼吸综合征冠状病毒2(SARS-CoV-2,即新冠病毒)是一种新型冠状病毒,于2019年末在中国武汉出现,随后成为全球大流行疾病。因此,其临床行为备受关注。初步报告显示,相当一部分患者的肝脏血液检查结果异常。在英国,格温特郡的新冠病毒感染率是最高的地区之一,而英国本身在全球范围内受新冠病毒的影响也位居前列。

方法

我们着手报告本院确诊为新冠病毒感染的住院患者在3周内肝脏血液检查异常的发生率、临床模式及严重程度。记录了诸如入住重症监护病房(ITU)、出院及死亡率等临床结局数据。

结果

318名住院的新冠病毒检测呈阳性患者有可供分析的肝脏血液检查结果。97名患者(31%)的一项或多项肝脏血液检查结果异常,其中64%在入院时即出现异常。与迄今为止的其他研究不同,肝脏检查主要表现为胆汁淤积(72%)。男性及肝脏血液检查异常与入住重症监护病房相关。

结论

近三分之一的新冠病毒感染住院患者存在肝脏血液检查异常,这些异常通常较轻,且与男性相关。重要的是,我们发现胆汁淤积模式占主导,但与入住重症监护病房或死亡并无明显关联。

相似文献

1
Incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with SARS-COV2 (COVID-19) in South Wales.南威尔士感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2,即新冠病毒)的住院患者肝脏血液检查异常的发生率、模式及严重程度
Frontline Gastroenterol. 2020 Aug 21;12(2):89-94. doi: 10.1136/flgastro-2020-101532. eCollection 2021.
2
Ethnic variation in outcome of people hospitalised during the first COVID-19 epidemic wave in Wales (UK): an analysis of national surveillance data using Onomap, a name-based ethnicity classification tool.威尔士(英国)首次 COVID-19 疫情期间住院患者结局的种族差异:使用基于姓名的种族分类工具 Onomap 对国家监测数据的分析。
BMJ Open. 2021 Aug 18;11(8):e048335. doi: 10.1136/bmjopen-2020-048335.
3
Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission.前瞻性拉丁美洲队列研究评估 COVID-19 患者入院时肝功能异常的结局。
Ann Hepatol. 2021 Mar-Apr;21:100298. doi: 10.1016/j.aohep.2020.100298. Epub 2021 Jan 7.
4
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.在医院环境中评估羟氯喹化学预防 SARS-CoV2 感染在医护人员中的疗效和安全性的对照、双盲、随机试验:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.
5
Impact of the Severity of Liver Injury in COVID-19 Patients Admitted to an Intensive Care Unit During the SARS-CoV2 Pandemic Outbreak.在严重急性呼吸综合征冠状病毒2(SARS-CoV2)大流行期间,入住重症监护病房的2019冠状病毒病(COVID-19)患者肝损伤严重程度的影响
J Crit Care Med (Targu Mures). 2021 Aug 5;7(3):211-216. doi: 10.2478/jccm-2021-0021. eCollection 2021 Jul.
6
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
7
Ethnic minority status as social determinant for COVID-19 infection, hospitalisation, severity, ICU admission and deaths in the early phase of the pandemic: a meta-analysis.少数民族身份是 COVID-19 感染、住院、严重程度、重症监护病房入院和死亡的社会决定因素:一项荟萃分析。
BMJ Glob Health. 2021 Nov;6(11). doi: 10.1136/bmjgh-2021-007433.
8
SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.SARS-CoV-2 感染肝脏直接导致 COVID-19 患者肝损伤。
J Hepatol. 2020 Oct;73(4):807-816. doi: 10.1016/j.jhep.2020.05.002. Epub 2020 May 11.
9
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.肝移植受者感染 SARS-CoV-2 后的结局:一项国际注册研究。
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):1008-1016. doi: 10.1016/S2468-1253(20)30271-5. Epub 2020 Aug 28.
10
Characteristics and outcomes of patients with COVID-19 and liver injury: a retrospective analysis and a multicenter experience.COVID-19 与肝损伤患者的特征和结局:一项回顾性分析及多中心经验。
Rom J Intern Med. 2022 Mar 17;60(1):49-55. doi: 10.2478/rjim-2021-0027. Print 2022 Mar 1.

引用本文的文献

1
Liver function as a predictor of mortality in COVID-19: A retrospective study.肝功能作为 COVID-19 患者死亡率的预测指标:一项回顾性研究。
Ann Hepatol. 2021 Dec;26:100553. doi: 10.1016/j.aohep.2021.100553. Epub 2021 Oct 6.
2
Gastroenterology 2021: from the heart of the COVID-19 pandemic.《胃肠病学》2021年:源自新冠疫情的核心地带
Frontline Gastroenterol. 2021 Feb 5;12(3):249-251. doi: 10.1136/flgastro-2021-101799. eCollection 2021.
3
Abnormal liver blood tests among hospitalised patients with SARS-CoV2 (COVID-19).
Frontline Gastroenterol. 2020 Nov 2;12(2):87-88. doi: 10.1136/flgastro-2020-101691. eCollection 2021.

本文引用的文献

1
Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort.新型冠状病毒肺炎相关急性肝损伤:在美国大型队列中的发生率及与临床结局的相关性。
Hepatology. 2020 Sep;72(3):807-817. doi: 10.1002/hep.31404.
2
Liver tests abnormalities in COVID-19: trick or treat?新冠病毒感染中的肝脏检查异常:是陷阱还是机遇?
J Hepatol. 2020 Nov;73(5):1275-1276. doi: 10.1016/j.jhep.2020.05.033. Epub 2020 May 27.
3
SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.SARS-CoV-2 感染肝脏直接导致 COVID-19 患者肝损伤。
J Hepatol. 2020 Oct;73(4):807-816. doi: 10.1016/j.jhep.2020.05.002. Epub 2020 May 11.
4
Liver Biochemistries in Hospitalized Patients With COVID-19.COVID-19 住院患者的肝功能生化指标。
Hepatology. 2021 Mar;73(3):890-900. doi: 10.1002/hep.31326. Epub 2020 Nov 4.
5
COVID-19: Abnormal liver function tests.COVID-19:肝功能异常。
J Hepatol. 2020 Sep;73(3):566-574. doi: 10.1016/j.jhep.2020.04.006. Epub 2020 Apr 13.
6
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study.中国湖北有消化道症状的 COVID-19 患者的临床特征:一项描述性、横断面、多中心研究。
Am J Gastroenterol. 2020 May;115(5):766-773. doi: 10.14309/ajg.0000000000000620.
7
Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease.2019冠状病毒病肝损伤的特征与机制
J Clin Transl Hepatol. 2020 Mar 28;8(1):13-17. doi: 10.14218/JCTH.2020.00019. Epub 2020 Mar 30.
8
Clinical course and mortality risk of severe COVID-19.重症新型冠状病毒肺炎的临床病程及死亡风险
Lancet. 2020 Mar 28;395(10229):1014-1015. doi: 10.1016/S0140-6736(20)30633-4. Epub 2020 Mar 17.
9
Liver injury during highly pathogenic human coronavirus infections.高致病性人冠状病毒感染期间的肝损伤。
Liver Int. 2020 May;40(5):998-1004. doi: 10.1111/liv.14435. Epub 2020 Mar 30.
10
Liver injury in COVID-19: management and challenges.新型冠状病毒肺炎中的肝损伤:管理与挑战
Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.